The influence of <i>SLC6A3</i> and <i>DRD2</i> polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease - Concepedia

Concepedia

Publication | Closed Access

The influence of <i>SLC6A3</i> and <i>DRD2</i> polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease

28

Citations

23

References

2018

Year

Erinaldo Ubirajara Damasceno dos Santos, Tiago Furtado Sampaio, Aléxia D Tenório dos Santos, Fernanda Capibaribe Leite, Ronaldo Carneiro da Silva, Sérgio Crovella, Amdore Guescel Asano, Nadja Maria Jorge Asano, Paulo Roberto Eleutério de Souza

Journal of Pharmacy and Pharmacology

Abstract

Clinical and demographic characteristics of Brazilian PD patients and differences in DRD2 and DAT1 genes may to determine individual variations in the therapeutic response to L-DOPA in the Brazilian PD patients.

References

	Year	Citations

Page 1